| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/24/2004 | EP1399474A2 Secreted proteins and their use |
| 03/24/2004 | EP1399473A2 Insecticidal proteins and synergistic combinations thereof |
| 03/24/2004 | EP1399472A2 Soluble heterodimeric cytokine receptor |
| 03/24/2004 | EP1399460A2 Breast cancer-associated genes and uses thereof |
| 03/24/2004 | EP1399183A2 Chimeric alphavirus replicon particles |
| 03/24/2004 | EP1399182A2 Papillomavirus vaccines |
| 03/24/2004 | EP1399181A2 Peptide vaccines against group a streptococci |
| 03/24/2004 | EP1399180A2 Sulfated ccr5 peptides for hiv-1 infection |
| 03/24/2004 | EP1399178A2 Method of treating metabolic disorders using neuronatin polypeptides |
| 03/24/2004 | EP1399177A1 Bmp binding proteins for use in bone or cartilage regeneration |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399174A2 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
| 03/24/2004 | EP1399023A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 03/24/2004 | EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/24/2004 | EP1194534A4 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 03/24/2004 | EP1150693B1 Immunogenic compositions for use as vaccines |
| 03/24/2004 | EP1121455A4 Zinc finger peptide cleavage of nucleic acids |
| 03/24/2004 | EP0946592B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 03/24/2004 | EP0900002B1 H2-m modified transgenic animals |
| 03/24/2004 | EP0871736B1 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 03/24/2004 | EP0869970B1 Endothelial cell proliferation inhibitor and its use |
| 03/24/2004 | EP0850319B1 Method for modulating cell apoptosis |
| 03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
| 03/24/2004 | EP0795015B1 Plasmids suitable for il-2 expression |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | EP0758341B1 FACTOR Xa INHIBITORS |
| 03/24/2004 | EP0726953B1 Human kunitz-type protease inhibitors |
| 03/24/2004 | EP0625212B1 Methods of detecting alzheimer's disease |
| 03/24/2004 | CN1484702A Novel bacillus thuringiensis insecticidal proteins |
| 03/24/2004 | CN1484700A Aop beta gene protein homologs fragments and thereof and their use for cell surface display |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484698A Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 03/24/2004 | CN1484696A Putrescine-N-Methyl transferase promoter |
| 03/24/2004 | CN1484692A Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing canceg said protooncogene |
| 03/24/2004 | CN1484651A Production of recombinant BMP-2 |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1483831A Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges |
| 03/24/2004 | CN1483821A Gene for controlling plant root system development and its coding products and use |
| 03/24/2004 | CN1483816A Colibacillns strain for recombination producing lectin of snowdrop and method thereof |
| 03/24/2004 | CN1483742A Protein related to carcinoma of urinary bladder and detection method thereof |
| 03/24/2004 | CN1483741A Novel human protein with cancer-suppressing function and coding sequence thereof |
| 03/24/2004 | CN1483740A Novel human protein with function for suppressing cancer and coding sequence thereof |
| 03/24/2004 | CN1483739A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1483738A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1483737A Specific protein of SARS virus, clinical detection method and kit |
| 03/24/2004 | CN1483736A Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods |
| 03/24/2004 | CN1142940C Pharmaceutical compsns. containing an MPL ligand |
| 03/23/2004 | US6710229 Plants having drought, cold, and/or salt tolerance |
| 03/23/2004 | US6710228 Heterologous sequence encoding a pesticidal lectin |
| 03/23/2004 | US6710227 Cyclin-dependent kinase inhibitors and uses thereof |
| 03/23/2004 | US6710226 Administering agent to induce immune response against amyloid deposit; drug screening, vaccines |
| 03/23/2004 | US6710173 Nucleic acid encoding modified viral env gene of hiv-1 isolate, comprising nucleotide segment encoding modified gp120 and gp41 complex, forming stabilizing disulfide bond between gp120 and gp41, enhancing binding to neutralizing antibodies |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710170 Polypeptides |
| 03/23/2004 | US6710169 Adheson variants |
| 03/23/2004 | US6710168 Vancomycin derivatives |
| 03/23/2004 | US6710167 Purifying insulin using stationary phase comprising pressure stable organic polymeric chromatography material and mobile phase comprising at least one water miscible organic solvent and at least one buffer substance, having ph from 7 to 11 |
| 03/23/2004 | US6710166 Isolated rcp41 protein comprising specified amino acid sequence; antigenic and effective to elicit immune response against cryptosporidium parvum in host animal |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710164 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710035 Interstitial introduction of an isolated polynucleotide into a tissue of the vertebrate where polynucleotide is taken up by the cells of the tissue and exerts a therapeutic effect on the vertebrate to provide immune response |
| 03/23/2004 | US6710033 Treating with anti-chlamydial agents to improve or sustain neurological function |
| 03/23/2004 | US6710031 Protein having antithrombotic activity and method for producing the same |
| 03/23/2004 | US6710030 Contortrostain (CN) and methods for its use in preventing metastasis and other conditions |
| 03/23/2004 | US6710027 Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709865 Isolated nucleic acid molecule comprising specified nucleotide sequence which encodes polypeptide having lipoxygenase activity; modulating development and defense response in plants |
| 03/23/2004 | US6709860 Construct comprising adipose-specific promoter operably linked to nucleotide sequence encoding polypeptide comprising specified amino acid sequence |
| 03/23/2004 | US6709851 Stabilization of helicobacter urease |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide |
| 03/23/2004 | US6709840 Anergy associated genes |
| 03/23/2004 | US6709839 SYK-UBP proteins, compositions and methods of use |
| 03/23/2004 | US6709838 Nucleic acid encoding patched-2 |
| 03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709830 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 03/23/2004 | US6709828 Immunoassay kit for detecting antibodies to hiv comprising a peptide corresponding to immunologically important epitopes of hiv |
| 03/23/2004 | US6709821 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/23/2004 | US6709814 Dimerization peptides that self-associate |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709661 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709659 Amino acid sequence 13 |
| 03/23/2004 | US6709657 Includes immunogenic fragment of at least 15 amino acids matching aligned contiguous segment of sequence 2 |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/23/2004 | US6708345 Necktie wearing device |
| 03/23/2004 | CA2336207C Ecdysone receptors and methods for their use |
| 03/19/2004 | CA2438778A1 Fusion proteins comprising hiv-nef and lngfr and methods of using same |
| 03/18/2004 | WO2004023137A2 Method for screening for mutant virus movement proteins (mp) |
| 03/18/2004 | WO2004023093A2 Target and method for inhibition of bacterial rna polymerase |
| 03/18/2004 | WO2004022763A1 Methods and means for improving retroviral integration |
| 03/18/2004 | WO2004022762A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | WO2004022760A1 Generation of recombinant influenza virus using baculovirus delivery vector |